Anúncio
Anúncio

ZYME

ZYME logo

Zymeworks Inc.

23.18
USD
Patrocinado
+0.08
+0.34%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

23.95

+0.77
+3.30%

Relatórios de Lucros ZYME

Rácio de surpresa positiva

ZYME separação 23 de 34 últimas estimativas.

68%

Próximo Relatório

Data do Próximo Relatório
03 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$14.13M
/
-$0.43
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-48.84%
/
+65.38%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-54.48%
/
+38.71%

Zymeworks Inc. earnings per share and revenue

On 06 de nov. de 2025, ZYME reported earnings of -0.26 USD per share (EPS) for Q3 25, beating the estimate of -0.32 USD, resulting in a 20.63% surprise. Revenue reached 27.61 milhão, compared to an expected 30.05 milhão, with a -8.10% difference. The market reacted with a -8.04% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 14 analistas forecast an EPS of -0.43 USD, with revenue projected to reach 14.13 milhão USD, implying an aumentar of 65.38% EPS, and diminuir of -48.84% in Revenue from the last quarter.
FAQ
For Q3 2025, Zymeworks Inc. reported EPS of -$0.26, beating estimates by 20.63%, and revenue of $27.61M, -8.1% below expectations.
The stock price moved down -8.04%, changed from $17.90 before the earnings release to $16.46 the day after.
The next earning report is scheduled for 03 de mar. de 2026.
Based on 14 analistas, Zymeworks Inc. is expected to report EPS of -$0.43 and revenue of $14.13M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio